Berylson Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ascendis Pharma A/S
ASND
|
+$4.84M |
| 2 |
Warby Parker
WRBY
|
+$4.15M |
| 3 |
Bilibili
BILI
|
+$3.62M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$3.49M |
| 5 |
Zillow
Z
|
+$2.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PENN Entertainment
PENN
|
+$2.97M |
| 2 |
RH
RH
|
+$2.48M |
| 3 |
BILL Holdings
BILL
|
+$2.09M |
| 4 |
Cloudflare
NET
|
+$1.72M |
| 5 |
Playboy Inc
PLBY
|
+$1.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.7% |
| 2 | Healthcare | 20.53% |
| 3 | Consumer Discretionary | 17.81% |
| 4 | Communication Services | 15.94% |
| 5 | Utilities | 5.05% |
Similar funds
Berylson Capital Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Berylson Capital Partners held 28 positions worth $60.5M, up 64% from $37M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Berylson Capital Partners deployed $30.3M of net new capital in Q3 2022, opening 8 new positions and adding to 9 existing holdings. Its largest new stake was Ascendis Pharma A/S: 51,000 shares worth $5.27M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 39% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Corpay, an estimated $119K trimmed.
- Berylson Capital Partners's largest Q3 2022 buy was Ascendis Pharma A/S: 51,000 shares worth $5.27M.
- Berylson Capital Partners added most to Warby Parker in Q3 2022, an estimated $4.15M increase.
- Berylson Capital Partners's biggest Q3 2022 reduction was Corpay, cutting an estimated $119K.
- Berylson Capital Partners fully exited PENN Entertainment in Q3 2022, selling an estimated $2.97M.
- Berylson Capital Partners's ten largest holdings make up 66% of its $60.5M portfolio in Q3 2022.
- Berylson Capital Partners opened 8 new positions and closed 5 in Q3 2022.
- Berylson Capital Partners's portfolio value rose 64% quarter-over-quarter to $60.5M.
Based on Berylson Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.